PATENT CLAIM ANALYSIS

Application Number: 15866787
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "654000"]

Abstract:
Disclosed herein are pharmaceutical compositions for nasal administration comprising tapentadol, their preparation and their use in the treatment of pain.

Claim (Index 14):
The method of  claim 10 , wherein the tapentadol mean Cmax-value achieved by said intranasal administration is equivalent to or greater than the tapentadol mean Cmax-value achieved by orally administering to a human a single dose of an immediate release composition comprising tapentadol or a pharmaceutically acceptable salt thereof in an amount that is equivalent to about 50 mg tapentadol free base.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 86.0
- Lexical Diversity: 1.04762
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15335145', '14882857', '14576357', '14950707', '12047388']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7361848794960415
- 35 USC 102 Novelty (BERT): 0.5249981801944963
- Combined Prediction Score: 0.715066209565887
- Mean Citation Score: 305.51074
- Max Citation Score: 314.98096
- Similarity Product: 221.1365791655349

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test